Bacteria That Causes Melioidosis Confirmed in Environmental Samples in Mississippi Gulf Coast
A bacteria that causes melioidosis has been found in the soil and water for the first time in the continental ...
Tag: Melioidosis
CDC Confirms Bacterial Strain in Aromatherapy Spray Sold at Walmart in Melioidosis Outbreak
CDC emphasized that consumers should not pour the contents down the drain or throw the bottle in the trash. Burkholderia ...
U.S. Navy Researchers Collaborate with Australian Melioidosis Expert to Study Pathogen Risks to Servicemembers in Indo-Pacific
A team of researchers from Naval Medical Research Center (NMRC) are working to understand the risks associated with Burkholderia pseudomallei ...
Study Shows Virulence of B. pseudomallei Strain in Aerosol Model
Burkholderia pseudomallei, the aetiological agent of melioidosis, causes a serious and often fatal disease in humans and animals. Novel medical ...
Focus on Melioidosis: Highlighted News and Research
Melioidosis, also called Whitmore's disease, is an infectious disease that can infect humans or animals. The disease is caused by ...
Naval Research Laboratory Seeks to Advance Field Diagnostics of Infectious Agents
The Naval Research Laboratory (NRL) is seeking partners to advance technology developed for in vitro diagnostic devices that are amenable ...
Fundamental Research to Counter Biological, Chemical, and Nuclear Weapons
The Defense Threat Reduction Agency (DTRA) seeks to identify, adopt, and adapt emerging, existing and revolutionary sciences that may demonstrate ...
Navy Researchers Work to Reduce Risk of Melioidosis Among Deployed Military
Dr. Kevin Schully, contractor and chief science officer with Naval Medical Research Center’s (NMRC) Austere environments Consortium for Enhanced Sepsis ...
Soligenix’s Innate Defense Regulator Selected for NIH Commercialization Transition Funding
The National Institutes of Health (NIH) has selected Soligenix's SGX942 (dusquetide) for the treatment of oral mucositis in head and ...
Collaboration Among BARDA, DTRA, USAMRIID and Spero to Advance SPR994
Spero Therapeutics, Inc. today announced that it was awarded funding of $15.7 million, with the potential for up to an additional $28.5 ...
